Multiple Sclerosis Global Support Network News

"Your trusted source for the latest in MS news and information."

  • MS Info Hub
  • MS News

AAN 2017: Early Treatment with Tecfidera and Tysabri Can Improve Outcomes

Kate Dawson, MD, VP, US Medical Biogen and team believes it’s imperative for patients diagnosed with multiple sclerosis (MS) to get treated early and...

AAN 2017: Aubagio and Cortical Atrophy by Robert Zivadinov, MD, PhD,...

At AAN 2017, Robert Zivadinov, MD, PhD, Professor of neurology, University at Buffalo, discussed the primary findings in the phase 3 randomized, placebo-controlled TOPIC...

AAN 2017: Merck Shows Data on Oral Cladribine Towards Multiple Sclerosis

Merck announced the presentation of new analyses of efficacy and safety data for investigational Cladribine Tablets in poster presentations at the Annual Meeting of...

AAN 2017 Coverage: Genzyme Displays More 6 Year Lemtrada Data

Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today positive new six-year investigational data from a post-hoc analysis of the extension...

AAN 2017 Coverage: Celgene Displays More Oral Ozanimod’s Multiple Sclerosis (MS)...

Efficacy and safety of the investigational therapy ozanimod were maintained out to two years in the blinded extension of the placebo-controlled phase 2/3 RADIANCE...

AAN 2017 Coverage – Pediatric Multiple Sclerosis Linked to Epstein-Barr, Herpes...

Prior exposure to Epstein-Barr virus (EBV) and herpes simplex virus type 1 (HSV-1), in addition to vitamin D deficiency, may increase the risk of...

AAN 2017 Coverage – New Aubagio (teriflunomide) Data Shows Reduction In...

Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today that new investigational data evaluating the effect of Aubagio® (teriflunomide) on cortical...

AAN 2017 Coverage – In Relapsing MS, Fatigue, Limb Problems May...

In patients with relapsing-remitting multiple sclerosis (RRMS), fatigue and lower limb problems may predict the risk of conversion to secondary progressive MS (SPMS). Results from...

Subscribe To Our Newsletter